# Lakefront Biotherapeutics

Lakefront Biotherapeutics is an Asset Manager based in Belgium.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Belgium
- **Region:** Europe
- **Assets under management:** Undisclosed
- **Website:** lakefrontbio.com

## Regulatory record

- **Reports private funds:** No

## About

Lakefront Biotherapeutics NV is incorporated in Belgium as a Naamloze Vennootschap, a legal form that grants it the capacity to raise capital and hold intellectual property. The NV structure is frequently used by European biotech platforms to compartmentalize risk around single-asset programs or to pool seed-stage investments before a traditional venture round. Without disclosed portfolio data, the strategy can be inferred from the Belgian biotech landscape, which clusters around Flanders and specializes in cell therapy, oncology, and neurology. A Belgian NV in this space typically participates in direct equity positions, often alongside Vlaams Instituut voor Biotechnologie (VIB) spinouts or university research commercialization offices. VIB alone has seeded over 30 biotech companies since 1996, and a parallel NV structure is a common vehicle for the initial capitalization of these ventures. No headcount, AUM, or deployment figures are publicly available. This pattern is consistent with incubation-phase biotechs that are capitalized at the low-single-digit millions of euros and operate with fewer than five professionals. An NV must adhere to stricter governance and capital maintenance rules under Belgian company law, which can make it a preferred vehicle for entities that anticipate future equity rounds or a listing on Euronext Brussels.

## Sectors

- Biotech

## Questions

### What is the legal structure of Lakefront Biotherapeutics NV?

The firm is incorporated as an NV (Naamloze Vennootschap) under Belgian law. This is a public limited liability company structure that requires a minimum share capital and is subject to stricter governance rules than a private BV. It signals a potential goal of eventually raising external institutional capital or listing on a public exchange. The NV form is typical for European biotech holding companies that intend to hold intellectual property and manage clinical-stage risk.

## Related profiles

- [PIMCO Dynamic Income Opportunities Fund](https://altss.com/profile/pimco-dynamic-income-opportunities-fund)
- [BLACKLINE](https://altss.com/profile/blackline-inc)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/lakefront-biotherapeutics-nv

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology